White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 55, Issue 8, Pages 1031-1046
Publisher
Oxford University Press (OUP)
Online
2012-08-14
DOI
10.1093/cid/cis688
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Pharmacokinetics of Metronidazole Evaluated Using Scavenged Samples from Preterm Infants
- (2012) Michael Cohen-Wolkowiez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meeting the Challenges of an Emerging Pathogen: The Henry Schueler 41&9 Foundation International Forum on Mucormycosis
- (2012) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Imbalanced Mortality Evidence for Tigecycline: 2011, the Year of the Meta-analysis
- (2012) P. E. Verde et al. CLINICAL INFECTIOUS DISEASES
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and Tolerability of Single-Dose Daptomycin in Young Infants
- (2012) Michael Cohen-Wolkowiez et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm Infants
- (2012) Michael Cohen-Wolkowiez et al. THERAPEUTIC DRUG MONITORING
- Frequentist and Bayesian Pharmacometric-Based Approaches To Facilitate Critically Needed New Antibiotic Development: Overcoming Lies, Damn Lies, and Statistics
- (2011) Paul G. Ambrose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
- (2011) Makoto Ohnishi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure
- (2011) Magnus Unemo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines
- (2011) S. O. Hjelmevoll et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections
- (2011) P. Brian Smith et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics of Moxifloxacin in an Infant With Mycoplasma hominis Meningitis
- (2011) Kevin M. Watt et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
- (2011) J. Dunne et al. PEDIATRICS
- Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock
- (2011) John D. Dickinson et al. Current Infectious Disease Reports
- Registration Trials of Antibacterial Drugs for the Treatment of Nosocomial Pneumonia
- (2010) Alfred Sorbello et al. CLINICAL INFECTIOUS DISEASES
- Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
- (2010) Brad Spellberg et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!
- (2010) Paul G. Ambrose et al. CLINICAL INFECTIOUS DISEASES
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
- (2009) David Gardiner et al. CLINICAL INFECTIOUS DISEASES
- Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea
- (2009) Young Kyoung Park et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Nosocomial Outbreak of Infection With Pan–Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital
- (2009) Raquel Valencia et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
- (2009) Ebbing Lautenbach et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006
- (2009) Marc S. Hoffmann et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London
- (2009) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
- (2009) N. C. Gordon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of Pharmacokinetics and Pharmacodynamics in a Failure Analysis of Community‐Acquired Pneumonia: Implications for Future Clinical Trial Study Design
- (2008) Paul G. Ambrose CLINICAL INFECTIOUS DISEASES
- Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia
- (2008) Peter E. Pertel et al. CLINICAL INFECTIOUS DISEASES
- Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients
- (2008) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
- (2008) M. S. Oliveira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
- (2008) K. Vasilev et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
- (2008) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More